Cargando…

1600. Long-Acting Antiretroviral Injectable: Who Would Benefit?

BACKGROUND: People with HIV (PWH) face many challenges in obtaining HIV care. Long-acting (LA)-injectable antiretroviral therapies (ART) can address some of these barriers. This project aimed to determine the percentage of patients who could receive the LA-injectable ART cabotegravir/rilpivirine (CA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pogorzelski, Karolina, Dandachi, Dima, Hitchcock, Nicole M, Fabricius, Michela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677661/ http://dx.doi.org/10.1093/ofid/ofad500.1435

Ejemplares similares

2499. Perceptions of and Preferences for Oral or Long-Acting Injectable Antiretroviral Treatment Regimens in the United States and Canada
por: Garris, Cindy, et al.
Publicado: (2019)

1559. Healthcare Staff Perceptions of Feasibility and Acceptability on Implementing Injectable HIV Pre-exposure Prophylaxis into Standard of Care: Baseline Results from the PrEP Implementation Study for Cabotegravir Long Acting for Men in the Real World (PILLAR)
por: Torres, Julian A, et al.
Publicado: (2023)

Long-acting injectable antiretrovirals for HIV treatment and prevention
por: Spreen, William R., et al.
Publicado: (2013)

1567. Perspectives of People with HIV (PWH) 6 Months Following a Switch to Cabotegravir and Rilpivirine Long-acting (CAB+RPV LA) in an Observational Real-world US Study (BEYOND)
por: Dandachi, Dima, et al.
Publicado: (2023)

1562. Renal Outcomes after Switch from Oral Antiretroviral therapy (ART) to Long-acting injectable Cabotegravir/Rilpivirine (LAI CAB)
por: Ayala, Alvaro, et al.
Publicado: (2023)

1600. Closing the gap on moxifloxacin breakpoints for Stenotrophomonas maltophilia
por: Stone, Tyler J, et al.
Publicado: (2020)

Long-Acting Injectable Antiretroviral Agents for HIV Treatment and Prevention
por: Kim, Yeon-Sook
Publicado: (2021)

Does prescribing long acting antipsychotic injection increase mortality or morbidity in patients who continue to use illicit drugs?
por: Sud, N.
Publicado: (2023)

Long-acting injectable antipsychotics during pregnancy: An update
por: Paraschakis, A., et al.
Publicado: (2021)

Breast Cancer Patients: Who Would Benefit from Neoadjuvant Chemotherapies?
por: Yao, Liqin, et al.
Publicado: (2022)

1770. The Association of Unmet Needs With Subsequent Retention in Care and HIV Suppression Among Hospitalized Patients With HIV Who Are Out of Care
por: Dandachi, Dima, et al.
Publicado: (2018)

Acceptability and feasibility of long-acting injectable antiretroviral therapy for HIV-infected persons who inject drugs in Vietnam: A qualitative study
por: Rutstein, Sarah E., et al.
Publicado: (2022)

Alternative initiation regimen of paliperidone palmitate long-acting injectable
por: Menendez Gil, I.E., et al.
Publicado: (2022)

The use of long-acting injectable antipsychotics in an acute psychiatric unit
por: Ortega-Hernández, G., et al.
Publicado: (2023)

2496. Qualitative Thematic Analysis of Social Media Data to Assess Perceptions of Daily Oral and Long-Acting Injectable Antiretroviral Treatment among People Living with HIV
por: Matza, Louis S, et al.
Publicado: (2019)

Long-acting injectable antiretroviral therapy: will it change the future of HIV treatment?
por: Brizzi, Marisa, et al.
Publicado: (2023)

Analysis of Oral versus Long-acting Injectable Antipsychotics in the Maintenance of Schizophrenia
por: Vasiliu, O.
Publicado: (2022)

Calderón, 1600-2000 /
Publicado: (2002)

Fable, c. 1600
por: Potter, Polyxeni
Publicado: (2002)

Efficacy and tolerability Aripiprazole once-monthly long-acting injectable in schizophrenia. Two-injection start regimen
por: Romero Guillena, S.L., et al.
Publicado: (2022)

Injectable long acting antiretroviral for HIV treatment and prevention: perspectives of potential users
por: Slama, Laurence, et al.
Publicado: (2023)

Who benefits most?
por: Van Diermen, L.
Publicado: (2021)

Identifying Participants Who Would Benefit the Most from an Adult Food-literacy Program
por: Begley, Andrea, et al.
Publicado: (2019)

Who would have thought a single Ki67 measurement would predict long-term outcome?
por: Dowsett, Mitch, et al.
Publicado: (2009)

The combination of long-acting injectable antipsychotics, a new key in resistant schizophrenia
por: Tascón Guerra, M.F., et al.
Publicado: (2022)

Aripirazole-Long Acting Injectable in Pregnant Women with Schizophrenia: A Case Series
por: Fernández-Abascal, B., et al.
Publicado: (2022)

Second Generation Long-Acting Injectable Antipsychotics in Africa: About a Case
por: Galvañ, J., et al.
Publicado: (2023)

1042. The Attitude of Patients With HIV about Telehealth for Their HIV Care
por: Dandachi, Dima, et al.
Publicado: (2020)

1034. Patient Perspectives on Implementation of a Long-Acting Injectable Antiretroviral Therapy Regimen in HIV US Healthcare Settings: Interim Results from the CUSTOMIZE study
por: Garris, Cindy, et al.
Publicado: (2020)

1585. The Annual Cost per Newly Virally-Suppressed Person with HIV in Those Starting Long-Acting Injectable Antiretroviral Therapy with Detectable Viremia in a Safety-Net Clinic in San Francisco
por: Marseille, Elliot, et al.
Publicado: (2023)

Catálogo novogalaico, 1600-1650 /
por: Hernández Bermejo, Evelia
Publicado: (1999)

The language of the heart, 1600–1750
por: Rousseau, G S
Publicado: (1998)

Obstetrics in Mexico Prior to 1600
por: Van Patten, Nathan
Publicado: (1932)

S229. CAN LONG-ACTING INJECTABLE PALIPERIDONE DOSING BE OPTIMIZED WITH PLASMA LEVEL MEASUREMENTS?
por: Zipursky, Robert, et al.
Publicado: (2018)

The effect of long-acting injectable antipsychotics on QRISK3 in patients with bipolar disorder and schizophrenia
por: Erbasan, V., et al.
Publicado: (2023)

1609. Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
por: Stout, Jacob, et al.
Publicado: (2023)

2498. Perceptions of Injectable Antiretrovirals in an Urban HIV Clinic
por: Koren, David E, et al.
Publicado: (2019)

Sciatica: predicting who would undergo surgery and who not
por: Gadjradj, Pravesh S., et al.
Publicado: (2022)

1600. Susceptibility of β-Lactam-Resistant Pseudomonas aeruginosa to Other β-Lactams: Is There Truly a Lack of Cross-Resistance?
por: Patel, Twisha S, et al.
Publicado: (2019)

PM399. Attitudes toward antipsychotic long-acting injections among patients with Schizophrenia in Japan.
por: Kudo, Shuhei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_obqschsblpqamsuih16r18gcn5